Sotera Health Company (SHC)
| Market Cap | 5.85B |
| Revenue (ttm) | 818.16M |
| Net Income (ttm) | -38.62M |
| Shares Out | 237.70M |
| EPS (ttm) | -0.16 |
| PE Ratio | n/a |
| Forward PE | 28.49 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 7 |
| Last Price | $24.61 |
| Previous Close | $23.54 |
| Change ($) | 1.07 |
| Change (%) | 4.55% |
| Day's Open | 23.65 |
| Day's Range | 23.49 - 24.69 |
| Day's Volume | 880,359 |
| 52-Week Range | 22.91 - 30.38 |
CLEVELAND, March 17, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the pricing of its secondary offering (the “Offering”) of 25,000,000 shares of its commo...
CLEVELAND, March 15, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par valu...
OAK BROOK, IL, March 10, 2021 (GLOBE NEWSWIRE) -- Sterigenics S.A.S., a subsidiary of Sotera Health and a global leader in comprehensive sterilization services, announces the expansion of its ethylene o...
CLEVELAND, March 09, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for...
CLEVELAND, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services f...
CLEVELAND, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services f...
CLEVELAND, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) today announced the closing of its initial public offering (“IPO”) of 53,590,000 shares of its common stock at a public o...
Sotera Health is a dominant player in sterilization of medical products. The company's products and services are very much in demand, as the company operates in a market which is hard to enter.
Sotera Health raised $1.1 billion with an initial public offering for the provider of medical sterilization, lab testing and advisory services. The Sotera IPO will begin trading Friday.
Shares of Sotera Health Co. started their public life with a rally Friday, as the first trade of the sterilization and lab-testing services provider's stock was 17.4% above the initial-public-offering p...
Shares of Sotera Health Co. are set to start trading Friday, after the Ohio-based sterilization and lab-testing services provider's initial public offering priced at the high end of the expected range. ...
CLEVELAND, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Sotera Health Company today announced the pricing of its initial public offering (“IPO”) of 46,600,000 shares of its common stock at a price to the public of...
Sotera has a stable, predictable and simple business model. Its services are essential and this is reflected in the fact that it has grown revenues every year since 2005.
About SHC
Sotera Health is a leading global provider of mission-critical sterilization and lab testing and advisory services to the medical device and pharmaceutical industries. We are driven by our mission: Safeguarding Global Health®. We provide end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers in the United States and around the world. Our customers include more than 40 of the t... [Read more...]
| Industry Diagnostics & Research | IPO Date Nov 20, 2020 |
| CEO Michael B. Petras, Jr. | Employees 3,000 |
| Stock Exchange NASDAQ | Ticker Symbol SHC |
Financial Performance
In 2020, Sotera Health's revenue was $818.16 million, an increase of 5.12% compared to the previous year's $778.33 million. Losses were -$38.62 million, 85.2% more than in 2019.
Analyst Forecasts
According to 8 analysts, the average rating for Sotera Health stock is "Buy." The 12-month stock price forecast is 33.38, which is an increase of 35.64% from the latest price.